BioSpace News Archive

LiVeritas Biosciences, Inc. announced the opening of a software development subsidiary in Manila, Philippines, dedicated to the development of rapid-turnaround mass spectrometry analytics and machine learning tools.

Quanta Therapeutics, a privately-held biopharmaceutical company pioneering complex-directed therapies to treat RAS-driven cancer types, today announced the appointment of Dr. Leonardo Faoro as Chief Medical Officer.

Chimeron Bio, an RNA company developing self-amplifying RNA vaccines and therapeutics designed on its proprietary ChaESAR™ RNA delivery platform, announced that Kevin Heyeck had been named Chief Executive Officer.

Disc Medicine, a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients living with serious hematologic diseases, presented five posters spanning several of its hematology programs at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition held in New Orleans, LA.

Veranex, the only truly comprehensive, global, tech-enabled service provider dedicated to the MedTech industry, announced today that it has acquired Fusion Biotec (Fusion), a design and engineering leader for complex electro-mechanical diagnostic instrumentation and medical devices located in Orange, California.

Research conducted at Florida Cancer Specialists & Research Institute, LLC that is contributing to global advancements in the diagnosis and treatment of blood diseases was presented at the American Society of Hematology 64th Annual Meeting and Exposition in New Orleans, Louisiana on Dec.

Nusano, Inc., a company reshaping the production of cancer-fighting radioisotopes, announced Chris Lowe as the company’s Chief Executive Officer.

Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a revenue-generating biotechnology company researching, developing, and commercializing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD)

Neurolief, a medical neurotechnology innovator, announces the appointment of Scott Drees as Chief Executive Officer and Director.

Nimble Therapeutics Inc., a leading peptide therapeutics company, announced they have achieved discovery milestones for two programs partnered with a large pharma company.